The United States represents a major market for cardiopulmonary autotransfusion systems, driven by the high volume of cardiovascular and complex surgical procedures performed annually. Strong adoption of patient blood management programs, advanced healthcare infrastructure, and increasing focus on reducing dependence on donor blood continue to support the demand for autotransfusion technologies...